SGH
GILD icon

Schonfeld Group Holdings’s Gilead Sciences GILD Stock Holding History

Schonfeld Group Holdings’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,712
Closed -$364K – 278
2015
Q3 		$364K Buy
+3,712
New +$412K 0.19% 107
2015
Q1 		– Sell
-4,563
Closed -$430K – 26
2014
Q4 		$430K Buy
+4,563
New +$472K 5.76% 6
2014
Q2 		– Sell
-4,600
Closed -$326K – 155
2014
Q1 		$326K Buy
+4,600
New +$361K 0.08% 355

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Schonfeld Group Holdings's GILD Position: Q4 2015 in Review

Schonfeld Group Holdings sold out of Gilead Sciences (GILD) in Q4 2015, closing a stake of 3,712 shares — an estimated $364K sold.

Schonfeld Group Holdings first reported a position in GILD in Q1 2014 and held it in 3 quarters. The position peaked at $430K in Q4 2014. 1,627 funds tracked by Wall St. Rank hold GILD as of Q4 2015.

  • Schonfeld Group Holdings reported no remaining Gilead Sciences position as of Q4 2015 after selling out during the quarter.
  • Schonfeld Group Holdings sold 3,712 Gilead Sciences shares in Q4 2015, an estimated $364K.
  • Schonfeld Group Holdings first reported a position in Gilead Sciences in Q1 2014 and held it in 3 quarters.
  • Schonfeld Group Holdings's Gilead Sciences position peaked at $430K in Q4 2014.
  • 1,627 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2015.

Based on Schonfeld Group Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.